journal cover

Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease

Therapeutic Advances in Gastroenterology

Jul 19, 2011

Chadwick WilliamsKevin Rioux

Abstract

Mesalazine [5-aminosalicylic acid (5-ASA)] has been used for over 30 years in the treatment of inflammatory bowel disease (IBD). It is a highly effective, safe, and well-tolerated drug for treatment of mild to moderate ulcerative colitis, which represents most patients with this disease...read more

Mentioned in this Paper

Malignant Tumor of Colon
Colorectal Neoplasms
Colitis
Mesalamine
Inflammatory Bowel Diseases
Malignant Neoplasm of Large Intestine
Crohn Disease
Ulcerative Colitis
Adherence (Attribute)
Colon Carcinoma
95
Paper Details
References
  • References43
  • Citations23
12345
  • References43
  • Citations23
123

Feeds With Similar Papers

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Related Papers

© 2020 Meta ULC. All rights reserved

Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease

Therapeutic Advances in Gastroenterology

Jul 19, 2011

Chadwick WilliamsKevin Rioux

PMID: 21765868

DOI: 10.1177/1756283x11405250

Abstract

Mesalazine [5-aminosalicylic acid (5-ASA)] has been used for over 30 years in the treatment of inflammatory bowel disease (IBD). It is a highly effective, safe, and well-tolerated drug for treatment of mild to moderate ulcerative colitis, which represents most patients with this disease...read more

Mentioned in this Paper

Malignant Tumor of Colon
Colorectal Neoplasms
Colitis
Mesalamine
Inflammatory Bowel Diseases
Malignant Neoplasm of Large Intestine
Crohn Disease
Ulcerative Colitis
Adherence (Attribute)
Colon Carcinoma
95

Feeds With Similar Papers

Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, arise due to chronic inflammation of the gastrointestinal tract. Here is the latest research.

Related Papers

World Journal of Gastroenterology : WJG

5-ASA in ulcerative colitis: improving treatment compliance(opens in new tab)

World Journal of Gastroenterology : WJGSeptember 19, 2009
C Prantera, Marina Rizzi
Paper Details
References
  • References43
  • Citations23
12345
  • References43
  • Citations23
123

Download from

Publisher
PubMed
/papers/optimizing-clinical-use-of-mesalazine-5-aminosalic/21765868